Drug IndexNexviazyme (avalglucosidase alfangpt)
Billing
Code: J0219
Description: Inj aval alfa-nqpt 4mg
Unit: 4 MG
Payment: $75.996
Pay quarter: Q2 2024
Covered in Part D: No
Drug Cost
Calculate drug cost and reimbursement
Total WAC:
$28,810.40Total Reimbursement:
$30,398.40(ASP: $28,677.74, Margin: $1,720.66)
.
.# Units to bill:
400Dosage & Frequency
Pompe disease
• 20mg/kg IV every 2 weeks if patient weighs 30kg or more
• 40mg/kg IV every 2 weeks if patient weighs less than 30kg
• 20mg/kg IV every 2 weeks if patient weighs 30kg or more
• 40mg/kg IV every 2 weeks if patient weighs less than 30kg
Billable NDCs
58468-0426-01
Nexviazyme (GENZYME CORPORATION)
100 mg
Prior Authorization
Resources